荷兰2018年狂犬病疫苗接种策略的成本评估
该研究构建决策树经济模型,从社会视角评估荷兰按2018年WHO建议实施不同狂犬病暴露前和暴露后干预方案的成本与成本效果。每避免一次狂犬病免疫球蛋白接种的增量成本为21,300至46,800欧元。
要点
- 2018年WHO狂犬病暴露前和暴露后建议变更降低了荷兰全国总成本。
- 提高旅行前疫苗接种率可减少暴露后免疫球蛋白接种,但总成本更高。
核心结论
- 2018年狂犬病暴露前和暴露后建议的变更降低了荷兰全国总成本。
- 提高旅行前疫苗接种率虽减少暴露后免疫球蛋白接种和暴露后疫苗接种,但总成本更高。
- 大规模皮内接种狂犬病疫苗可降低暴露前预防总成本并可能提高接种率,但仍属昂贵干预。
研究设计与样本
- 构建基于决策树的经济模型,从社会视角评估荷兰不同狂犬病暴露前和暴露后干预方案的成本与成本效果。
- 比较不同WHO暴露前预防建议、肌内与皮内接种以及风险人群接种覆盖率提高后的暴露后预防成本。
- 成本效果以每避免一次狂犬病免疫球蛋白接种的增量成本表示,并评估旅行者数量和疫苗接种覆盖率相关的统计不确定性。
主要发现
- 提高疫苗接种覆盖率导致总体成本更高。
- 每避免一次狂犬病免疫球蛋白接种的增量成本为21,300至46,800欧元。
临床怎么用
- 在制定狂犬病暴露前预防策略时,可优先考虑皮内接种以降低总成本。
- 提高风险人群旅行前疫苗接种率可减少暴露后免疫球蛋白使用,但需权衡总成本增加。
- 成本效果分析可为卫生决策者选择狂犬病预防干预方案提供依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BackgroundThe risk of contracting rabies is low for travellers. However, the number of Dutch travellers potentially exposed abroad following an animal-associated injury and needing post-exposure prophylaxis (PEP) has increased, resulting in increased costs.AimHere, we evaluated the costs and the cost-effectiveness of different pre- and post-exposure interventions in the Netherlands, taking into account the 2018 World Health Organization (WHO) recommendations for the prevention of rabies.MethodsA decision tree-based economic model was constructed. We calculated and compared the cost of different WHO pre-exposure prophylaxis (PrEP) recommendations, intramuscular vs intradermal vaccination and PEP subsequent to increased vaccination coverage in risk groups. We estimated cost-effectiveness, expressed as incremental costs per rabies immunoglobulin (RIG) administration averted, using a societal perspective. Statistical uncertainty regarding number of travellers and vaccination coverage was assessed.ResultsTotal costs at the national level were highest using previous WHO recommendations from 2012, estimated at EUR 15.4 million annually. Intradermal vaccinations in combination with the current recommendations led to the lowest costs, estimated at EUR 10.3 million. Higher vaccination uptake resulted in higher overall costs. The incremental costs per RIG administration averted varied from EUR 21,300-46,800.ConclusionsThe change in rabies PrEP and PEP recommendations in 2018 reduced total costs. Strategies with increased pre-travel vaccination uptake led to fewer RIG administrations and fewer vaccinations after exposure but also to higher total costs. Although larger scale intradermal administration of rabies vaccine can reduce total costs of PrEP and can positively influence vaccination uptake, it remains a costly intervention.
引用
- Suijkerbuijk AW, Mangen MJ, Haverkate MR, et al. Rabies vaccination strategies in the Netherlands in 2018: a cost evaluation. Euro Surveill. 2020. PMID: 32975187. doi:10.2807/1560-7917.ES.2020.25.38.1900716
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。